Overview

Pharmacokinetic Study of Testosterone Enanthate

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
Relative Bioavailability and Safety comparison of 3 formulations of Testosterone Enanthate.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Antares Pharma Inc.
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate